Go to:
Logótipo
Você está em: Start > Publications > View > REXO2 Is an Oligoribonuclease Active in Human Mitochondria
Map of Premises
Principal
Publication

REXO2 Is an Oligoribonuclease Active in Human Mitochondria

Title
REXO2 Is an Oligoribonuclease Active in Human Mitochondria
Type
Article in International Scientific Journal
Year
2013
Authors
Francesco Bruni
(Author)
Other
The person does not belong to the institution. The person does not belong to the institution. The person does not belong to the institution. Without AUTHENTICUS Without ORCID
Pasqua Gramegna
(Author)
Other
The person does not belong to the institution. The person does not belong to the institution. The person does not belong to the institution. Without AUTHENTICUS Without ORCID
Robert N Lightowlers
(Author)
Other
The person does not belong to the institution. The person does not belong to the institution. The person does not belong to the institution. Without AUTHENTICUS Without ORCID
Zofia M A Chrzanowska Lightowlers
(Author)
Other
The person does not belong to the institution. The person does not belong to the institution. The person does not belong to the institution. Without AUTHENTICUS Without ORCID
Journal
Title: PLoS ONEImported from Authenticus Search for Journal Publications
Vol. 8 No. 1
Final page: e64670
ISSN: 1932-6203
Other information
Authenticus ID: P-005-0MJ
Abstract (EN): The Escherichia coli oligoribonuclease, ORN, has a 3' to 5' exonuclease activity specific for small oligomers that is essential for cell viability. The human homologue, REXO2, has hitherto been incompletely characterized, with only its in vitro ability to degrade small single-stranded RNA and DNA fragments documented. Here we show that the human enzyme has clear dual cellular localization being present both in cytosolic and mitochondrial fractions. Interestingly, the mitochondrial form localizes to both the intermembrane space and the matrix. Depletion of REXO2 by RNA interference causes a strong morphological phenotype in human cells, which show a disorganized network of punctate and granular mitochondria. Lack of REXO2 protein also causes a substantial decrease of mitochondrial nucleic acid content and impaired de novo mitochondrial protein synthesis. Our data constitute the first in vivo evidence for an oligoribonuclease activity in human mitochondria.
Language: English
Type (Professor's evaluation): Scientific
No. of pages: 11
Documents
We could not find any documents associated to the publication.
Related Publications

Of the same journal

Reliability in long-term clinical studies of disease-modifying therapies for relapsing-remitting multiple sclerosis: A systematic review (2020)
Another Publication in an International Scientific Journal
Lucchetta, RC; Leonart, LP; Goncalves, MVM; Becker, J; Pontarolo, R; Fernandez Llimos, F; Wiens, A
Questionnaires measuring movement behaviours in adults and older adults: Content description and measurement properties. A systematic review (2022)
Another Publication in an International Scientific Journal
Rodrigues, B; Encantado, J; Carraca, E; Sousa Sa, E; Lopes, L; Cliff, D; Mendes, R; Silva, MN; Godinho, C; Santos, R
Mapping the characteristics of network meta-analyses on drug therapy: A systematic review (2018)
Another Publication in an International Scientific Journal
Tonin, FS; Steimbach, LM; Mendes, AM; Borba, HH; Pontarolo, R; Fernandez Llimos, F
Fecal microbiota transplantation in inflammatory bowel disease patients: A systematic review and meta-analysis (2020)
Another Publication in an International Scientific Journal
Caldeira, LD; Borba, HH; Tonin, FS; Wiens, A; Fernandez Llimos, F; Pontarolo, R
Establishing the criterion validity of self-report measures of adherence in hemodialysis through associations with clinical biomarkers: A systematic review and meta-analysis (2022)
Another Publication in an International Scientific Journal
Sousa, H; Ribeiro, O; Costa, E; Christensen, AJ; Figueiredo, D

See all (436)

Recommend this page Top
Copyright 1996-2025 © Faculdade de Medicina Dentária da Universidade do Porto  I Terms and Conditions  I Acessibility  I Index A-Z
Page created on: 2025-07-19 at 01:35:53 | Privacy Policy | Personal Data Protection Policy | Whistleblowing | Electronic Yellow Book